[1] Ittrich H,Bockhorn M,Klose H,et al. The diagnosis and treatment of hemoptysis[J]. Dtsch Arztebl Int, 2017, 114: 371- 381.
[2] Davidson K,Shojaee S. Managing massive hemoptysis[J]. Chest, 2020, 157: 77- 88.
[3] Radchenko C,Alraiyes AH,Shojaee S. A systematic approach to the management of massive hemoptysis[J]. J Thorac Dis, 2017, 9: S1069- S1086.
[4] Lee Y,Lee M,Hur S,et al. Bronchial and non- bronchial systemic artery embolization with transradial access in patients with hemoptysis[J]. Diagn Interv Radiol, 2022, 28: 359- 363.
[5] Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review[J]. Diagn Interv Radiol, 2017, 23: 307- 317.
[6] Abid N,Loukil M,Mokni A,et al. Outcomes of bronchial artery embolization for the management of hemoptysis[J]. Tunis Med, 2021, 99: 264- 268.
[7] Pizarro C,Meyer C,Schmidt J,et al. Haemoptysis[J]. Pneumologie, 2023, 77:173- 183.
[8] 项松鹤,王美璐,匡慧慧,等. 热带地区血液病患者肺部感染病原菌分析[J]. 解放军医学院学报, 2018, 39:655- 658.
[9] Carteaux G,Contou D,Voiriot G,et al. Severe hemoptysis associated with bacterial pulmonary infection: clinical features, significance of parenchymal necrosis, and outcome[J]. Lung, 2018, 196: 33- 42.
[10] 刘未邦,邓 妍,魏志喜,等. 老年慢性阻塞性肺疾病合并肺部感染患者病原菌分布及其血清炎症因子的变化[J]. 中国老年学杂志, 2023, 43:3391- 3393.
[11] El- Baba F,Gao Y,Soubani AO. Pulmonary aspergillosis: what the generalist needs to know[J]. Am J Med, 2020, 133: 668- 674.
[12] 梁筠仪,王皓翔,张奕昭,等. 老年慢性阻塞性肺疾病患者血清炎性因子水平及与肺部感染的相关性[J]. 中国老年学杂志,2023, 43:1830- 1833.
[13] Diel R,Ewig S,Blaas S,et al. Incidence of patients with non- cystic fibrosis bronchiectasis in Germany: a healthcare insurance claims data analysis[J]. Respir Med, 2019, 151: 121- 127.
[14] 支气管扩张症专家共识撰写协作组,中华医学会呼吸病学分会感染学组. 中国成人支气管扩张症诊断与治疗专家共识[J].中华结核和呼吸杂志, 2021, 44:311- 321.
[15] Giang NT, Dung LT, Hien NT, et al. Hemoptysis from complex pulmonary aspergilloma treated by cavernostomy and thoracoplasty[J]. BMC Surg, 2019, 19: 187.
[16] Boccia D,Bond V. The catastrophic cost of tuberculosis: advancing research and solutions[J]. Int J Tuberc Lung Dis, 2019, 23: 1129- 1130.
[17] Allwood BW,Byrne A,Meghji J,et al. Post- tuberculosis lung disease: clinical review of an under- recognised global challenge[J]. Respiration, 2021, 100: 751- 763.
[18] Meghji J,Lesosky M,Joekes E,et al. Patient outcomes associated with post- tuberculosis lung damage in Malawi: a prospective cohort study[J]. Thorax, 2020, 75: 269- 278.
[19] 翟 婷,王 盼,王 源,等. 基于“邪伏肺络”理论论治支气管扩张症[J]. 北京中医药大学学报, 2023, 46:853- 858.
[20] Walker CM, Rosado- de- Christenson ML, Martinez- Jimenez S, et al. Bronchial arteries: anatomy, function, hypertrophy, and anomalies[J]. Radiographics, 2015, 35: 32- 49.
[21] Liu Y,Cheng Y. Combined development of traditional Chinese medicine and interventional medicine[J]. J Interv Med, 2021, 4: 136- 138.
[22] Almeida J, Leal C, Figueiredo L. Evaluation of the bronchial arteries: normal findings, hypertrophy and embolization in patients with hemoptysis[J]. Insights Imaging, 2020, 11: 70.
[23] Yan HT, Lu GD, Liu J, et al. Does the presence of systemic artery- pulmonary circulation shunt during bronchial arterial embolization increase the recurrence of noncancer- related hemoptysis? A retrospective cohort study[J]. Respir Res, 2023, 24: 119.
[24] Zheng Z,Zhuang Z,Yang M,et al. Bronchial artery embolization for hemoptysis: a systematic review and meta- analysis[J]. J Interv Med, 2021, 4: 172- 180.
[25] 张文浩,叶丽芳,任医民,等. 选择性动脉栓塞术治疗咯血效果及复发相关因素分析[J]. 介入放射学杂志, 2020, 29:35- 38.
[26] 严海涛,施海彬,张金星,等.非肿瘤性咯血二次支气管动脉栓塞治疗效果及预后因素分析[J].介入放射学杂志,2022,31:446- 450.